RPRX
Price:
$39.15
Market Cap:
$17.00B
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematol...[Read more]
Industry
Biotechnology
IPO Date
2020-06-16
Stock Exchange
NASDAQ
Ticker
RPRX
According to Royalty Pharma plc’s latest financial reports and current stock price. The company's current ROE is 15.20%. This represents a change of 306.69% compared to the average of 3.74% of the last 4 quarters.
The mean historical ROE of Royalty Pharma plc over the last ten years is 18.29%. The current 15.20% ROE has changed -16.88% with respect to the historical average. Over the past ten years (40 quarters), RPRX's ROE was at its highest in in the December 2019 quarter at 23.26%. The ROE was at its lowest in in the December 2022 quarter at -8.10%.
Average
18.29%
Median
15.06%
Minimum
0.76%
Maximum
38.47%
Discovering the peaks and valleys of Royalty Pharma plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.18%
Maximum Annual ROE = 38.47%
Minimum Annual Increase = -92.91%
Minimum Annual ROE = 0.76%
| Year | ROE | Change |
|---|---|---|
| 2024 | 12.37% | -28.88% |
| 2023 | 17.39% | 2.18% |
| 2022 | 0.76% | -92.91% |
| 2021 | 10.73% | -46.98% |
| 2020 | 20.23% | -47.40% |
| 2019 | 38.47% | 25.31% |
| 2018 | 30.70% | 13.16% |
| 2017 | 27.13% | 113.10% |
| 2016 | 12.73% | 2.39% |
The current ROE of Royalty Pharma plc (RPRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
10.17%
5-year avg
12.30%
10-year avg
18.29%
Royalty Pharma plc’s ROE is less than Genmab A/S (24.67%), less than United Therapeutics Corporation (18.83%), less than Incyte Corporation (29.83%), less than Fresenius Medical Care AG & Co. KGaA (4.70%), greater than Summit Therapeutics Inc. (-311.15%), less than Smith & Nephew plc (9.14%), greater than Roivant Sciences Ltd. (-8.05%), less than Hologic, Inc. (11.74%), less than Tenet Healthcare Corporation (33.61%), less than Exelixis, Inc. (31.64%),
| Company | ROE | Market cap |
|---|---|---|
| 24.67% | $19.72B | |
| 18.83% | $21.63B | |
| 29.83% | $19.72B | |
| 4.70% | $13.70B | |
| -311.15% | $14.00B | |
| 9.14% | $14.31B | |
| -8.05% | $14.73B | |
| 11.74% | $16.69B | |
| 33.61% | $18.64B | |
| 31.64% | $11.90B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Royalty Pharma plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Royalty Pharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Royalty Pharma plc's ROE?
How is the ROE calculated for Royalty Pharma plc (RPRX)?
What is the highest ROE for Royalty Pharma plc (RPRX)?
What is the 3-year average ROE for Royalty Pharma plc (RPRX)?
What is the 5-year average ROE for Royalty Pharma plc (RPRX)?
How does the current ROE for Royalty Pharma plc (RPRX) compare to its historical average?